From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis

References

• 1 Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 423, 356–361 (2003).
  Medline CASGoogle Scholar
• 2 Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 4, S265 (2002).
  MedlineGoogle Scholar
• 3 Edrees AF, Misra SN, Abdou NI. Anti-tumor necrosis factor (TNF) therapy in rheumatoid arthritis: correlation of TNF-α serum level with clinical response and benefit from changing dose or frequency of infliximab infusions. Clin. Exp. Rheumatol. 23, 469–474.
  MedlineGoogle Scholar
• 4 Inui K, Koike T. Combination therapy with biologic agents in rheumatic diseases: current and future prospects. Ther. Adv. Musculoskelet. Dis. 8, 192–202 (2016).
  Medline CASGoogle Scholar
• 5 Upchurch KS, Kay J. Evolution of treatment for rheumatoid arthritis Rheumatology (Oxford) 51(Suppl. 6), vi28–vi36 (2012).
  Medline CASGoogle Scholar
• 6 Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J. Rheumatol. 36, 1118–1125 (2009).
  Medline CASGoogle Scholar
• 7 Singh JA, Christensen R, Wells GA et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. In: Cochrane Database of Systematic Reviews. Singh JA (Ed.). John Wiley & Sons, Ltd, Chichester, UK, p CD007848 (2009).
  Google Scholar
• 8 Raimondo MG, Biggioggero M, Crotti C, Becciolini A, Favalli EG. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis. Drug Des. Devel. Ther. 11, 1593–1603 (2017).
  Medline CASGoogle Scholar
• 9 Tanaka T, Narazaki M, Kishimoto T. Interleukin (IL-6) immunotherapy. Cold Spring Harb. Perspect. Biol. a028456 (2017).
  MedlineGoogle Scholar
• 10 Emery P, Keystone E, Tony HP et al. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann. Rheum. Dis. 67, 1516–1523 (2008).
  Medline CASGoogle Scholar
• 11 Favalli EG, Desiati F, Atzeni F et al. Serious infections during anti-TNFα treatment in rheumatoid arthritis patients. Autoimmun. Rev. 8, 266–273 (2009).
  Medline CASGoogle Scholar
• 12 Inanc N, Direskeneli H. Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis. Rheumatol. Int. 27, 67–71 (2006).
  Medline CASGoogle Scholar
• 13 Yamanaka H. TNF as a target of inflammation in rheumatoid arthritis. Endocr. Metab. Immune Disord. Drug Targets 15, 129–134 (2015).
  Medline CASGoogle Scholar
• 14 Ulloa L, Quiroz-Gonzalez S, Torres-Rosas R. Nerve stimulation: immunomodulation and control of inflammation. Trends Mol. Med. 23, 1103–1120 (2017).
  MedlineGoogle Scholar
• 15 Tracey KJ. The inflammatory reflex. Nature 420, 853–859 (2002).
  Medline CASGoogle Scholar
• 16 Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and therapeutic relevance of neuro-immune communication. Immunity 46, 927–942 (2017).
  Medline CASGoogle Scholar
• 17 Hoover DB. Cholinergic modulation of the immune system presents new approaches for treating inflammation. Pharmacol. Ther. 179, 1–16 (2017).
  Medline CASGoogle Scholar
• 18 Waldburger J-M, Firestein GS. Regulation of peripheral inflammation by the central nervous system. Curr. Rheumatol. Rep. 12, 370–378 (2010).
  Medline CASGoogle Scholar
• 19 Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
  Medline CASGoogle Scholar
• 20 Bonaz B, Sinniger V, Pellissier S. Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease. J. Intern. Med. 282, 46–63 (2017).
  Medline CASGoogle Scholar
• 21 De Herdt V, Puimege L, De Waele J et al. Increased rat serum corticosterone suggests immunomodulation by stimulation of the vagal nerve. J. Neuroimmunol. 212, 102–105 (2009).
  Medline CASGoogle Scholar
• 22 Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP. Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis. J. Intern. Med. 282, 64–75 (2017).
  Medline CASGoogle Scholar
• 23 van Maanen MA, Vervoordeldonk MJ, Tak PP. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat. Rev. Rheumatol. 5, 229–232 (2009).
  Medline CASGoogle Scholar
• 24 Bassi GS, Dias DPM, Franchin M et al. Modulation of experimental arthritis by vagal sensory and central brain stimulation. Brain, Behav. Immun. 64, 330–343 (2017).
  MedlineGoogle Scholar
• 25 Tak PP. Interview with Paul-Peter Tak: stimulating the vagus nerve to treat rheumatoid arthritis. Bioelectron. Med. 1(1), 17–20 (2018).
  Google Scholar
• 26 Levine YA, Koopman FA, Faltys M et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PloS ONE 9, e104530 (2014).
  MedlineGoogle Scholar
• 27 Koopman FA, Chavan SS, Miljko S et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 113, 8284–8289 (2016).
  Medline CASGoogle Scholar
• 28 Martelli D, McKinley MJ, McAllen RM. The cholinergic anti-inflammatory pathway: a critical review. Auton. Neurosci. 182, 65–69 (2014).
  Medline CASGoogle Scholar
• 29 Bassi GS, Ulloa L, Santos VR et al. Cortical stimulation in conscious rats controls joint inflammation. Progress in neuro-psychopharmacology and biological psychiatry. 84, 201–213 (2018).
  Google Scholar
• 30 Cai B, Dong W, Sharpe S, Deitch EA, Ulloa L. Survival and inflammatory responses in experimental models of hemorrhage. J. Surg. Res. 169, 257–266 (2011).
  MedlineGoogle Scholar
• 31 Ulloa L, Deitch EA. Neuroimmune perspectives in sepsis. Crit. Care 13, 133 (2009).
  MedlineGoogle Scholar
• 32 Ulloa L, Tracey KJ. The ‘cytokine profile’: a code for sepsis. Trends Mol. Med. 11, 56–63 (2005).
  Medline CASGoogle Scholar
• 33 Kanashiro A, Sônego F, Ferreira RG et al. Therapeutic potential and limitations of cholinergic anti-inflammatory pathway in sepsis. Pharmacol. Res. 117, 1–8 (2017).
  Medline CASGoogle Scholar
• 34 Cai B, Deitch EA, Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm. 2010, 1–10 (2010).
  Google Scholar
• 35 Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat. Rev. Drug Discov. 4, 673–684 (2005).
  Medline CASGoogle Scholar
• 36 Rasmussen SE, Pfeiffer-Jensen M, Drewes AM et al. Vagal influences in rheumatoid arthritis. Scand. J. Rheumatol. 47, 1–11 (2018).
  Medline CASGoogle Scholar
• 37 Zhang Q, Lu Y, Bian H, Guo L, Zhu H. Activation of the α7 nicotinic receptor promotes lipopolysaccharide-induced conversion of M1 microglia to M2. Am. J. Transl. Res. 9, 971–985 (2017).
  Medline CASGoogle Scholar
• 38 Pinheiro NM, Santana FPR, Almeida RR et al. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile. FASEB J. 31, 320–332 (2017).
  MedlineGoogle Scholar
• 39 Watkins LR, Goehler LE, Relton JK et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci. Lett. 183, 27–31 (1995).
  Medline CASGoogle Scholar
• 40 Ardell JL, Rajendran PS, Nier HA, KenKnight BH, Armour JA. Central-peripheral neural network interactions evoked by vagus nerve stimulation: functional consequences on control of cardiac function. Am. J. Physiol. Heart Circ. Physiol. 309, H1740-52 (2015).
  MedlineGoogle Scholar
• 41 Kember G, Ardell JL, Armour JA, Zamir M. Vagal nerve stimulation therapy: what is being stimulated? PLoS ONE 9, e114498 (2014).
  MedlineGoogle Scholar
• 42 Rosas-Ballina M, Olofsson PS, Ochani M et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334, 98–101 (2011).
  Medline CASGoogle Scholar
• 43 Rosas-Ballina M, Ochani M, Parrish WR et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl Acad. Sci. USA 105, 11008–11013 (2008).
  Medline CASGoogle Scholar
• 44 Bratton BO, Martelli D, McKinley MJ, Trevaks D, Anderson CR, McAllen RM. Neural regulation of inflammation: no neural connection from the vagus to splenic sympathetic neurons. Exp. Physiol. 97, 1180–1185 (2012).
  Medline CASGoogle Scholar
• 45 Romanovsky AA. The inflammatory reflex: the current model should be revised. Exp. Physiol. 97, 1178–1179 (2012).
  MedlineGoogle Scholar
• 46 Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S. Unexpected finding of a marked non-neuronal cholinergic system in human knee joint synovial tissue. Neurosci. Lett. 442, 128–133 (2008).
  Medline CASGoogle Scholar
• 47 Vida G, Peña G, Deitch EA, Ulloa L. α7-cholinergic receptor mediates vagal induction of splenic norepinephrine. J. Immunol. 186, 4340–4346 (2011).
  Medline CASGoogle Scholar
• 48 Vida G, Peña G, Kanashiro A et al. β2-adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. FASEB J. 25, 4476–4485 (2011).
  Medline CASGoogle Scholar
• 49 Pena G, Cai B, Ramos L, Vida G, Deitch EA, Ulloa L. Cholinergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis. J. Immunol. 187, 718–725 (2011).
  Medline CASGoogle Scholar
• 50 Pavlov VA, Tracey KJ. Neural circuitry and immunity. Immunol. Res. 63, 38–57 (2015).
  Medline CASGoogle Scholar
• 51 Huston JM, Ochani M, Rosas-Ballina M et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623–1628 (2006).
  Medline CASGoogle Scholar
• 52 Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2002).
  MedlineGoogle Scholar
• 53 Bernik TR, Friedman SG, Ochani M et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J. Vas. Surg. 36, 1231–1236 (2002).
  MedlineGoogle Scholar
• 54 Altavilla D, Guarini S, Bitto A et al. Activation of the cholinergic anti-inflammatory pathway reduces NF-κB activation, blunts TNF-α production, and protects againts splanchic artery occlusion shock. Shock 25, 500–506 (2006).
  Medline CASGoogle Scholar
• 55 Cai B, Chen F, Ji Y et al. Alpha7 cholinergic-agonist prevents systemic inflammation and improves survival during resuscitation. J. Cell. Mol. Med. 13, 3774–3785 (2009).
  MedlineGoogle Scholar
• 56 Grech D, Li Z, Morcillo P et al. Intraoperative low-frequency electroacupuncture under general anesthesia improves postoperative recovery in a randomized trial. J. Acupunct. Meridian Stud. 9, 234–241 (2016).
  MedlineGoogle Scholar
• 57 van Westerloo DJ, Giebelen IA, Florquin S et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822–1830 (2006).
  Medline CASGoogle Scholar
• 58 Wang H, Liao H, Ochani M et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216–1221 (2004).
  Medline CASGoogle Scholar
• 59 van Westerloo DJ, Giebelen IAJ, Florquin S et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191, 2138–2148 (2005).
  Medline CASGoogle Scholar
• 60 Tracey KJ, Fong Y, Hesse DG et al. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662–664 (1987).
  Medline CASGoogle Scholar
• 61 Carré JE, Singer M. Cellular energetic metabolism in sepsis: the need for a systems approach. Biochim. Biophys. Acta 1777, 763–771 (2008).
  Medline CASGoogle Scholar
• 62 Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G. Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4, 89–95 (1995).
  Medline CASGoogle Scholar
• 63 Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J. Immunol. 148, 2724–2730 (1992).
  Medline CASGoogle Scholar
• 64 Peña G, Cai B, Liu J et al. Unphosphorylated STAT3 modulates alpha7 nicotinic receptor signaling and cytokine production in sepsis. Eur. J. Immunol. 40, 2580–2589 (2010).
  Medline CASGoogle Scholar
• 65 Peña G, Cai B, Deitch EA, Ulloa L. JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J. Mol. Med. 88, 851–859 (2010).
  Medline CASGoogle Scholar
• 66 Ulloa L. The cholinergic anti-inflammatory pathway meets microRNA. Cell Res. 23, 1249–1250 (2013).
  Medline CASGoogle Scholar
• 67 Pullan RD, Rhodes J, Ganesh S et al. Transdermal nicotine for active ulcerative colitis. N. Engl. J. Med. 330, 811–815 (1994).
  Medline CASGoogle Scholar
• 68 Cho Y-G, Cho M-L, Min S-Y, Kim H-Y. Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis. Autoimmun. Rev. 7, 65–70 (2007).
  Medline CASGoogle Scholar
• 69 Lindblad SS, Mydel P, Jonsson I-M, Senior RM, Tarkowski A, Bokarewa M. Smoking and nicotine exposure delay development of collagen-induced arthritis in mice. Arthritis Res. Ther. 11, R88 (2009).
  MedlineGoogle Scholar
• 70 van Maanen MA, Lebre MC, van der Poll T et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60, 114–122 (2009).
  Medline CASGoogle Scholar
• 71 Li T, Zuo X, Zhou Y et al. The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. J. Clin. Immunol. 30, 213–220 (2010).
  MedlineGoogle Scholar
• 72 van Maanen MA, Stoof SP, LaRosa GJ, Vervoordeldonk MJ, Tak PP. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor 7 subunit gene knockout mice. Ann. Rheum. Dis. 69, 1717–1723 (2010).
  Medline CASGoogle Scholar
• 73 Bruchfeld A, Goldstein RS, Chavan S et al. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J. Intern. Med. 268, 94–101 (2010).
  Medline CASGoogle Scholar
• 74 Waldburger J-M, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 58, 3439–3449 (2008).
  Medline CASGoogle Scholar
• 75 Wu S, Luo H, Xiao X, Zhang H, Li T, Zuo X. Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur. J. Pharmacol. 735, 97–104 (2014).
  Medline CASGoogle Scholar
• 76 Yang Y, Yang Y, Yang J, Xie R, Ren Y, Fan H. Regulatory effect of nicotine on collagen-induced arthritis and on the induction and function of in vitro-cultured Th17 cells. Mod. Rheumatol. 24, 781–787 (2014).
  Medline CASGoogle Scholar
• 77 Li S, Zhou B, Liu B et al. Activation of the cholinergic anti-inflammatory system by nicotine attenuates arthritis via suppression of macrophage migration. Mol. Med. Rep. 14, 5057–5064 (2016).
  Medline CASGoogle Scholar
• 78 Kotake S, Udagawa N, Takahashi N et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Invest. 103, 1345–1352 (1999).
  Medline CASGoogle Scholar
• 79 Shahrara S, Pickens SR, Dorfleutner A, Pope RM. IL-17 induces monocyte migration in rheumatoid arthritis. J. Immunol. 182, 3884–3891 (2009).
  Medline CASGoogle Scholar
• 80 Ziolkowska M, Koc A, Luszczykiewicz G et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164, 2832–2838 (2000).
  Medline CASGoogle Scholar
• 81 Ivanov II, McKenzie BS, Zhou L et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
  Medline CASGoogle Scholar
• 82 Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. immunol. 6, 1133–1141 (2005).
  Medline CASGoogle Scholar
• 83 Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
  Medline CASGoogle Scholar
• 84 Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235–238 (2006).
  Medline CASGoogle Scholar
• 85 Hoeve MA, Savage NDL, de Boer T et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur. J. Immunol. 36, 661–670 (2006).
  Medline CASGoogle Scholar
• 86 Wang D, Zhou R, Yao Y et al. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J. Pharmacol. Exp. Ther. 335, 553–561 (2010).
  Medline CASGoogle Scholar
• 87 Grando SA, Pittelkow MR, Schallreuter KU. Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J. Investig. Dermatol. 126, 1948–1965 (2006).
  Medline CASGoogle Scholar
• 88 Leite PEC, Gandía L, de Pascual R et al. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice. Brain Res. 1573, 27–36 (2014).
  Medline CASGoogle Scholar
• 89 Kurzen H, Berger H, Jäger C et al. Phenotypical and molecular profiling of the extraneuronal cholinergic system of the skin. J. Investig. Dermatol. 123, 937–949 (2004).
  Medline CASGoogle Scholar
• 90 Pereira MR, Leite PEC. The involvement of parasympathetic and sympathetic nerve in the inflammatory reflex. J. Cell. Physiol. 231, 1862–1869 (2016).
  Medline CASGoogle Scholar
• 91 Westman M, Engström M, Catrina AI, Lampa J. Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand. J. Immunol. 70, 136–140 (2009).
  Medline CASGoogle Scholar
• 92 Van Maanen MA, Stoof SP, Van Der Zanden EP et al. The α7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum. 60, 1272–1281 (2009).
  MedlineGoogle Scholar
• 93 Zhou Y, Zuo X, Li Y, Wang Y, Zhao H, Xiao X. Nicotine inhibits tumor necrosis factor-α induced IL-6 and IL-8 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Rheumatol. Int. 32, 97–104 (2012).
  Medline CASGoogle Scholar
• 94 Hosseinzadeh A, Thompson PR, Segal BH, Urban CF. Nicotine induces neutrophil extracellular traps. J. Leukoc. Biol. 100, 1105–1112 (2016).
  Medline CASGoogle Scholar
• 95 Lee J, Luria A, Rhodes C et al. Nicotine drives neutrophil extracellular traps formation and accelerates collagen-induced arthritis. Rheumatology (Oxford) 56, kew449 (2016).
  Google Scholar
• 96 Baka Z, Buzás E, Nagy G. Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Res. Ther. 11, 238 (2009).
  MedlineGoogle Scholar
• 97 Yu H, Yang Y-H, Rajaiah R, Moudgil KD. Nicotine-induced differential modulation of autoimmune arthritis in the Lewis rat involves changes in interleukin-17 and anti-cyclic citrullinated peptide antibodies. Arthritis Rheum. 63, 981–991 (2011).
  Medline CASGoogle Scholar
• 98 Härle P, Möbius D, Carr DJJ, Schölmerich J, Straub RH. An opposing time-dependent immune-modulating effect of the sympathetic nervous system conferred by altering the cytokine profile in the local lymph nodes and spleen of mice with type II collagen-induced arthritis. Arthritis Rheum. 52, 1305–1313 (2005).
  MedlineGoogle Scholar
• 99 Härle P, Pongratz G, Albrecht J, Tarner IH, Straub RH. An early sympathetic nervous system influence exacerbates collagen-induced arthritis via CD4+CD25+ cells. Arthritis Rheum. 58, 2347–2355 (2008).
  MedlineGoogle Scholar
• 100 Miller LE, Jüsten HP, Schölmerich J, Straub RH. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 14, 2097–2107 (2000).
  Medline CASGoogle Scholar
• 101 Capellino S, Cosentino M, Wolff C et al. Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann. Rheum. Dis. 69, 1853–1860 (2010).
  Medline CASGoogle Scholar
• 102 Pongratz G, Melzer M, Straub RH. The sympathetic nervous system stimulates anti-inflammatory B cells in collagen-type II-induced arthritis. Ann. Rheum. Dis. 71, 432–439 (2012).
  Medline CASGoogle Scholar
• 103 Buijs RM, van der Vliet J, Garidou M-L, Huitinga I, Escobar C. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS ONE 3, e3152 (2008).
  MedlineGoogle Scholar
• 104 McAllen RM, Cook AD, Khiew HW, Martelli D, Hamilton JA. The interface between cholinergic pathways and the immune system and its relevance to arthritis. Arthritis Res. Ther. 17, 87 (2015).
  MedlineGoogle Scholar
• 105 Li T, Zuo X, Zhou Y et al. The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. J. Clin. Immunol. 30, 213–220 (2010).
  MedlineGoogle Scholar
• 106 Simons CT, Kulchitsky VA, Sugimoto N, Homer LD, Székely M, Romanovsky AA. Signaling the brain in systemic inflammation: which vagal branch is involved in fever genesis? Am. J. Physiol. 275, R63-R68 (1998).
  Google Scholar
• 107 Kimpel D, Dayton T, Fuseler J et al. Splenectomy attenuates streptococcal cell wall-induced arthritis and alters leukocyte activation. Arthritis Rheum. 48, 3557–3567 (2003).
  MedlineGoogle Scholar
• 108 Rahman J, Staines NA. Contribution of the spleen, lymph nodes and bone marrow to the antibody response in collagen-induced arthritis in the rat. Clin. Exp. Immunol. 85, 48–54 (1991).
  Medline CASGoogle Scholar
• 109 Bassi GS, Brognara F, Castania JA et al. Baroreflex activation in conscious rats modulates the joint inflammatory response via sympathetic function. Brain Behav. Immun. 49, 140–147 (2015).
  Medline CASGoogle Scholar
• 110 Balint GP, Balint PV. Felty's syndrome. Best pract. Res. Clin. Rheumatol. 18, 631–645 (2004).
  MedlineGoogle Scholar
• 111 Bradley JD, Pinals RS. Felty's syndrome presenting without arthritis. Clin. Exp. Rheumatol. 1, 257–259 (1983).
  Medline CASGoogle Scholar
• 112 Uluhan A, Sager D, Jasin HE. Juvenile rheumatoid arthritis and common variable hypogammaglobulinemia. J. Rheumatol. 25, 1205–1210 (1998).
  Medline CASGoogle Scholar
• 113 Matteoli G, Gomez-Pinilla PJ, Nemethova A et al. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut 63, 938–948 (2014).
  Medline CASGoogle Scholar
• 114 Olofsson PS, Lavine Y, Caravaca A et al. Single-pulse and unidirectional electrical activation of the cervical vagus nerve reduces tumor necrosis factor in endotoxemia. Bioelectron. Med. 2, 37–42 (2015).
  Google Scholar
• 115 Inoue T, Abe C, Sung SJ et al. Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury through α7nAChR+ splenocytes. J. Clin. Investig. 126, 1939–1952 (2016).
  MedlineGoogle Scholar
• 116 Verlinden TJM, Rijkers K, Hoogland G, Herrler A. Morphology of the human cervical vagus nerve: implications for vagus nerve stimulation treatment. Acta Neurol. Scand. 133, 173–182 (2016).
  Medline CASGoogle Scholar
• 117 Seki A, Green HR, Lee TD et al. Sympathetic nerve fibers in human cervical and thoracic vagus nerves. Heart Rhythm 11, 1411–1417 (2014).
  MedlineGoogle Scholar
• 118 Kox M, van Eijk LT, Zwaag J et al. Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proc. Natl Acad. Sci. USA 111, 7379–7384 (2014).
  Medline CASGoogle Scholar
• 119 Martelli D, Yao ST, Mancera J, McKinley MJ, McAllen RM. Reflex control of inflammation by the splanchnic anti-inflammatory pathway is sustained and independent of anesthesia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 307, R1085–R1091 (2014).
  Medline CASGoogle Scholar
• 120 Elenkov IJ, Haskó G, Kovács KJ, Vizi ES. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by selective alpha- and beta-adrenergic drugs in mice. J. Neuroimmunol. 61, 123–131 (1995).
  Medline CASGoogle Scholar
• 121 Abe C, Inoue T, Inglis MA et al. C1 neurons mediate a stress-induced anti-inflammatory reflex in mice. Nat. Neurosci. 20, 700–707 (2017).
  Medline CASGoogle Scholar
• 122 Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced recognition memory following vagus nerve stimulation in human subjects. Nat. Neurosci. 2, 94–98 (1999).
  Medline CASGoogle Scholar
• 123 Barnes A, Duncan R, Chisholm JA et al. Investigation into the mechanisms of vagus nerve stimulation for the treatment of intractable epilepsy, using 99mTc-HMPAO SPET brain images. Eur. J. Nucl. Med. Mol. Imaging 30, 301–305 (2003).
  MedlineGoogle Scholar
• 124 Henry TR, Bakay RA, Votaw JR et al. Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 39, 983–990 (1998).
  Medline CASGoogle Scholar
• 125 Naritoku DK, Terry WJ, Helfert RH. Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res. 22, 53–62 (1995).
  Medline CASGoogle Scholar
• 126 Cunningham JT, Mifflin SW, Gould GG, Frazer A. Induction of c-Fos and DeltaFosB immunoreactivity in rat brain by vagal nerve stimulation. Neuropsychopharmacology 33, 1884–1895 (2008).
  Medline CASGoogle Scholar
• 127 Thompson M, Bywaters EG. Unilateral rheumatoid arthritis following hemiplegia. Ann. Rheum. Dis. 21, 370–377 (1962).
  Medline CASGoogle Scholar
• 128 Glick EN. Asymmetrical rheumatoid arthritis after poliomyelitis. BMJ 3, 26–28 (1967).
  Medline CASGoogle Scholar
• 129 Hamilton S. Unilateral rheumatoid arthritis in hemiplegia. J. Can. Assoc. Radiol. 34, 49–50 (1983).
  Medline CASGoogle Scholar
• 130 Lapadula G, Iannone F, Zuccaro C, Covelli M, Grattagliano V, Pipitone V. Recovery of erosive rheumatoid arthritis after human immunodeficiency virus-1 infection and hemiplegia. J. Rheumatol. 24, 747–751 (1997).
  Medline CASGoogle Scholar
• 131 Stangenberg L, Burzyn D, Binstadt BA et al. Denervation protects limbs from inflammatory arthritis via an impact on the microvasculature. Proc. Natl Acad. Sci. USA 111, 11419–11424 (2014).
  Medline CASGoogle Scholar
• 132 Coderre TJ, Chan AK, Helms C, Basbaum AI, Levine JD. Increasing sympathetic nerve terminal-dependent plasma extravasation correlates with decreased arthritic joint injury in rats. Neuroscience 40, 185–189 (1991).
  Medline CASGoogle Scholar
• 133 Green PG, Miao FJ, Jänig W, Levine JD. Negative feedback neuroendocrine control of the inflammatory response in rats. The J. Neurosci. 15, 4678–4686 (1995).
  Medline CASGoogle Scholar
• 134 Miao FJ, Jänig W, Levine JD. Vagal branches involved in inhibition of bradykinin-induced synovial plasma extravasation by intrathecal nicotine and noxious stimulation in the rat. J. Physiol. 498(Pt 2), 473–481 (1997).
  MedlineGoogle Scholar
• 135 Miao FJ, Green PG, Coderre TJ, Jänig W, Levine JD. Sympathetic-dependence in bradykinin-induced synovial plasma extravasation is dose-related. Neurosci. Lett. 205, 165–168 (1996).
  Medline CASGoogle Scholar
• 136 Miao FJ, Jänig W, Dallman MF et al. Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotine. J. Neurophysiol. 72, 1199–1207 (1994).
  Medline CASGoogle Scholar
• 137 Martelli D, Yao ST, McKinley MJ, McAllen RM. Reflex control of inflammation by sympathetic nerves, not the vagus. J. Physiol. 592, 1677–1686 (2014).
  Medline CASGoogle Scholar
• 138 Willemze RA, Luyer MD, Buurman WA, de Jonge WJ. Neural reflex pathways in intestinal inflammation: hypotheses to viable therapy. Nat. Rev. Gastroenterol. Hepatol. 12, 353–362 (2015).
  Medline CASGoogle Scholar
• 139 Levine YA, Koopman FA, Faltys M et al. Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS ONE 9, e104530 (2014).
  MedlineGoogle Scholar
• 140 Schaible H-G, Straub RH. Function of the sympathetic supply in acute and chronic experimental joint inflammation. Auton. Neurosci. 182, 55–64 (2014).
  MedlineGoogle Scholar
• 141 Sato Y, Schaible HG. Discharge characteristics of sympathetic efferents to the knee joint of the cat. J. Auton. Nerv. Sys. 19, 95–103 (1987).
  Medline CASGoogle Scholar
• 142 Benarroch EE. The arterial baroreflex: functional organization and involvement in neurologic disease. Neurology 71, 1733–1738 (2008).
  MedlineGoogle Scholar
• 143 Vitale F, Litt B. Bioelectronics: the promise of leveraging the body's circuitry to treat disease. Bioelectron. Med. 1, 3–7 (2018).
  Google Scholar
• 144 Rehman AA, Elmore KB, Mattei TA. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes. Neurosurg. focus 38, E14 (2015).
  MedlineGoogle Scholar
• 145 Shawki MM, Farid A. Low electric field parameters required to induce death of cancer cells. Electromagn. Biol. Med. 33, 159–163 (2014).
  Medline CASGoogle Scholar
• 146 Birmingham K, Gradinaru V, Anikeeva P et al. Bioelectronic medicines: a research roadmap. Nat. Rev. Drug Dis. 13, 399–400 (2014).
  Medline CASGoogle Scholar
• 147 Suzuki K, Nakai A. Immune modulation by neuronal electric shock waves. J. Allergy Clin. Immunol. doi: 10.1016/j.jaci.2018.02.027 (2018) (Epub ahead of print).
  Google Scholar
• 148 Murray K, Reardon C. The cholinergic anti-inflammatory pathway revisited. Neurogastroenterol. Motil. 30, e13288 (2018).
  Google Scholar
• 149 Botha C, Farmer AD, Nilsson M et al. Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity. Gut 64, 611–617 (2015).
  Medline CASGoogle Scholar
• 150 Wheless JW, Baumgartner J. Vagus nerve stimulation therapy. Drugs Today 40, 501–515 (2004).
  MedlineGoogle Scholar
• 151 Carreno FR, Frazer A. Vagal nerve stimulation for treatment-resistant depression. Neurotherapeutics 14, 716–727 (2017).
  MedlineGoogle Scholar
• 152 Mwamburi M, Liebler EJ, Tenaglia AT. Review of non-invasive vagus nerve stimulation (gammaCore): efficacy, safety, potential impact on comorbidities, and economic burden for episodic and chronic cluster headache. Am. J. Manag. Care 23, S317–S325 (2017).
  MedlineGoogle Scholar
• 153 Simon B, Blake J. Mechanism of action of non-invasive cervical vagus nerve stimulation for the treatment of primary headaches. Am. J. Manag. care 23, S312–S316 (2017).
  MedlineGoogle Scholar
• 154 Stefan H, Kreiselmeyer G, Kerling F et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: a proof of concept trial. Epilepsia 53, e115–e118 (2012).
  MedlineGoogle Scholar
• 155 Lerman I, Hauger R, Sorkin L et al. Noninvasive transcutaneous vagus nerve stimulation decreases whole blood culture-derived cytokines and chemokines: a randomized, blinded, healthy control pilot trial. Neuromodulation 19, 283–290 (2016).
  MedlineGoogle Scholar
• 156 Brock C, Brock B, Aziz Q et al. Transcutaneous cervical vagal nerve stimulation modulates cardiac vagal tone and tumor necrosis factor-alpha. Neurogastroenterol. Motil. 29, e12999 (2017).
  Google Scholar
• 157 Zhao YX, He W, Jing XH et al. Transcutaneous auricular vagus nerve stimulation protects endotoxemic rat from lipopolysaccharide-induced inflammation. Evid.-Based Complementary Altern. Med. 2012, 1–10 (2012).
  Google Scholar
• 158 Nakai A, Hayano Y, Furuta F, Noda M, Suzuki K. Control of lymphocyte egress from lymph nodes through β ₂ -adrenergic receptors. J. Exp. Med. 211, 2583–2598 (2014).
  Medline CASGoogle Scholar
• 159 Kanashiro A, Talbot J, Peres RS et al. Neutrophil recruitment and articular hyperalgesia in antigen-induced arthritis are modulated by the cholinergic anti-inflammatory pathway. Basic Clin. Pharmacol. Toxicol. 119, 453–457 (2016).
  Medline CASGoogle Scholar
• 160 Gowayed MA, Refaat R, Ahmed WM, El-Abhar HS. Effect of galantamine on adjuvant-induced arthritis in rats. Eur. J. Pharmacol. 764, 547–553 (2015).
  Medline CASGoogle Scholar
• 161 Malfait AM, Malik AS, Marinova-Mutafchieva L, Butler DM, Maini RN, Feldmann M. The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J. Immunol. 162, 6278–6283 (1999).
  Medline CASGoogle Scholar
• 162 Cobelens PM, Kavelaars A, Vroon A et al. The beta 2-adrenergic agonist salbutamol potentiates oral induction of tolerance, suppressing adjuvant arthritis and antigen-specific immunity. J. Immunol. 169, 5028–5035 (2002).
  MedlineGoogle Scholar
• 163 Pavlov VA, Ochani M, Gallowitsch-Puerta M et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl Acad. Sci. USA 103, 5219–5223 (2006).
  Medline CASGoogle Scholar
• 164 Beckmann J, Dittmann N, Schütz I, Klein J, Lips KS. Effect of M3 muscarinic acetylcholine receptor deficiency on collagen antibody-induced arthritis. Arthritis Res. Ther. 18, 17 (2016).
  MedlineGoogle Scholar
• 165 Delgado M, Abad C, Martinez C et al. Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J. Mol. Med. 80, 16–24 (2002).
  Medline CASGoogle Scholar
• 166 Kanashiro A, Franchin M, Bassi GS et al. Inhibition of spinal p38 MAPK prevents articular neutrophil infiltration in experimental arthritis via sympathetic activation. Fundam. Clin. Pharmacol. 32, 155–162 (2017).
  MedlineGoogle Scholar
• 167 Bassi GS, do C Malvar D, Cunha TM, Cunha FQ, Kanashiro A. Spinal GABA-B receptor modulates neutrophil recruitment to the knee joint in zymosan-induced arthritis. Naunyn Schmiedeberg Arc. Pharmacol. 389, 851–861 (2016).
  CASGoogle Scholar
• 168 Boyle DL, Jones TL, Hammaker D et al. Regulation of peripheral inflammation by spinal p38 MAP kinase in rats. PLoS Med. 3, e338 (2016).
  Google Scholar
• 169 Bruchfeld A, Goldstein RS, Chavan S et al. Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J. Intern. Med. 268, 94–101 (2010).
  Medline CASGoogle Scholar
• 170 Evrengul H, Dursunoglu D, Cobankara V et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 24, 198–202 (2004).
  MedlineGoogle Scholar
• 171 Goldstein RS, Bruchfeld A, Yang L et al. Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210–215 (2007).
  Medline CASGoogle Scholar
• 172 Koopman FA, Tang MW, Vermeij J et al. Autonomic dysfunction precedes development of rheumatoid arthritis: a prospective cohort study. EBioMedicine 6, 231–237 (2016).
  Medline CASGoogle Scholar
• 173 Holman AJ, Ng E. Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. Auton. Neurosci. 143, 58–67 (2008).
  Medline CASGoogle Scholar
• 174 Gigliotti JC, Huang L, Ye H et al. Ultrasound prevents renal ischemia-reperfusion injury by stimulating the splenic cholinergic anti-inflammatory pathway. J. Am. Soc. Nephrol. 24, 1451–1460 (2013).
  Medline CASGoogle Scholar
• 175 Torres-Rosas R, Yehia G, Pena G et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat. Med. 20, 291–295 (2014).
  Medline CASGoogle Scholar
• 176 Zhu J, Chen X-Y, Li L-B et al. Electroacupuncture attenuates collagen-induced arthritis in rats through vasoactive intestinal peptide signalling-dependent re-establishment of the regulatory T cell/T-helper 17 cell balance. Acupunct. Med. 33, 305–311 (2015).
  MedlineGoogle Scholar
• 177 Li J, Li J, Chen R, Cai G. Targeting NF-κB and TNF-α activation by electroacupuncture to suppress collagen-induced rheumatoid arthritis in model rats. Altern. Ther. Health Med. 21, 26–34 (2015).
  MedlineGoogle Scholar
• 178 Dong Z-Q, Zhu J, Lu D, Chen Q, Xu Y. Effect of electroacupuncture in ‘Zusanli’ and ‘Kunlun’ acupoints on TLR4 signaling pathway of adjuvant arthritis rats. Am. J. Ther. 25, 314–319 (2018).
  Google Scholar
• 179 Ouyang B, Gao J, Che J et al. Effect of electro-acupuncture on tumor necrosis factor-α and vascular endothelial growth factor in peripheral blood and joint synovia of patients with rheumatoid arthritis. Chin. J. Integr. Med. 17, 505–509 (2011).
  MedlineGoogle Scholar
• 180 Lu J-H, Liu Y-Q, Deng Q-W, Peng Y-P, Qiu Y-H. Dopamine D2 receptor is involved in alleviation of Type II collagen-induced arthritis in mice. BioMed Res. Int. 2015, 496759 (2015).
  MedlineGoogle Scholar
• 181 Révész D, Rydenhag B, Ben-Menachem E. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J. Neurosurg. Pediatr. 18, 97–104 (2016).
  MedlineGoogle Scholar
• 182 Kahlow H, Olivecrona M. Complications of vagal nerve stimulation for drug-resistant epilepsy. Seizure 22, 827–833 (2013).
  MedlineGoogle Scholar
• 183 Engel O, Akyüz L, da Costa Goncalves AC et al. Cholinergic pathway suppresses pulmonary innate immunity facilitating pneumonia after stroke. Stroke 46, 3232–3240 (2015).
  Medline CASGoogle Scholar
• 184 Prass K, Meisel C, Höflich C et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell Type 1–like immunostimulation. J. Exp. Med. 198, 725–736 (2003).
  Medline CASGoogle Scholar
• 185 Wong CHY, Jenne CN, Lee W-Y, Léger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101–105 (2011).
  Medline CASGoogle Scholar
• 186 Irmler IM, Gajda M, Kamradt T. Amelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function. Ann. Rheum. Dis. 73, 2183–2191 (2014).
  Medline CASGoogle Scholar